Tumor-Associated Macrophages in Cancer Growth and Progression

Research output: Chapter in Book/Report/Conference proceedingChapter


This chapter reviews the key properties of tumor-associated macrophages (TAMs), emphasizing on the genetic evidence and the emerging targets for therapeutic intervention. TAMs derive from the circulating monocytes and are recruited at the tumor site by a tumor-derived chemotactic factor for monocytes. TAMs that have immunoregulatory and immunosuppressive activity produce growth factors that stimulate angiogenesis, remodel tissues, and facilitate invasion and metastasis. TAMs and the related immature myeloid suppressor cells have the properties of M2 macrophage populations that are supportive to tumors. In many human tumors, a high frequency of infiltrating TAMs is associated with poor prognosis. TAMs participate in the proangiogenic process by producing the angiogenic factor thymidine phosphorylase (TP), which promotes the endothelial cell migration in vitro and whose levels of expression are associated with tumor neovascularization. TAMs contribute to tumor progression also by producing proangiogenic and tumor-inducing chemokines, such as CCL2. Moreover, TAMs accumulate in the hypoxic regions of tumors, and hypoxia triggers a proangiogenic program in these cells.

Original languageEnglish
Title of host publicationCancer Immunotherapy
PublisherElsevier Inc.
Number of pages19
ISBN (Print)9780123725516
Publication statusPublished - 2007

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Tumor-Associated Macrophages in Cancer Growth and Progression'. Together they form a unique fingerprint.

Cite this